Seminars in Oncology
Volume 33 , Pages S35-S40 , October 2006

Combined Vascular Endothelial Growth Factor–Targeted Therapy and Radiotherapy for Rectal Cancer: Theory and Clinical Practice

  • Christopher G. Willett

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC.
    • Corresponding Author InformationAddress reprint requests to Christopher G. Willett, MD, Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.
  • ,
  • Sergey V. Kozin

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • ,
  • Dan G. Duda

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • ,
  • Emmanuelle di Tomaso

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • ,
  • Kevin R. Kozak

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • ,
  • Yves Boucher

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
  • ,
  • Rakesh K. Jain

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.
    • Dr Jain is a consultant to AstraZeneca Pharmaceuticals, GLG, Nektar Therapeutics, and ThromboGenics.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by grants from the National Institutes of Health-National Cancer Institute (R21-CA 99237 to C.G.W. and P01-CA80124 and R01-CA115767 to R.K.J.), the National Foundation for Cancer Research (to R.K.J. and C.G.W.), and the American Association for Cancer Research (to D.G.D.).

PII: S0093-7754(06)00318-6

doi: 10.1053/j.seminoncol.2006.08.007

Seminars in Oncology
Volume 33 , Pages S35-S40 , October 2006